Available online on 15.02.2026 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2026 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Effect of Jasminum sambac on Stress-Induced Anxiety in Mice
Nidhi Dangi*, Akash Sharma, Brajmohan Kaushal
Sagar Institute of Pharmaceutical Sciences, NH-26, Narsinghpur Road, Sironja, Sagar (M.P.) India- 470228
|
Article Info: __________________ _____________________________ Article History: Received 17 Nov 2025 Reviewed 12 Jan 2026 Accepted 31 Jan 2026 Published 15 Feb 2026 _______________________________________________ Cite this article as: Dangi N, Sharma A, Kaushal B, Effect of Jasminum sambac on Stress-Induced Anxiety in Mice, Journal of Drug Delivery and Therapeutics. 2026; 16(2):182-191 DOI: http://dx.doi.org/10.22270/jddt.v16i2.7573 _______________________________________________ For Correspondence: Ms Nidhi Dangi, Sagar Institute of Pharmaceutical Sciences, NH-26, Narsinghpur Road, Sironja, Sagar (M.P.) India- 470228 |
Abstract _______________________________________________________________________________________________________________ Background: Anxiety disorders are prevalent neuropsychiatric conditions that significantly impair quality of life. Although conventional anxiolytic drugs are effective, their use is limited by adverse effects, prompting the search for safer alternatives from medicinal plants. Jasminum sambac has been traditionally used for central nervous system disorders, but its anxiolytic potential lacks scientific validation. Objective: This study aimed to evaluate the anxiolytic activity of the ethanolic leaf extract of Jasminum sambac in experimental animals. Methods: The ethanolic leaf extract of Jasminum sambac was prepared and subjected to preliminary phytochemical screening. Anxiolytic activity was assessed in Swiss albino mice using the Elevated Plus Maze, Light and Dark Box, Open Field Test, and Forced Swim Test. Biochemical parameters including plasma nitrate, inducible nitric oxide synthase, acetylcholinesterase, monoamine oxidase-A and -B, and glutathione reductase were estimated. Diazepam (4 mg/kg) served as the standard drug. Data were analyzed using one-way ANOVA followed by Dunnett’s test. Results: The extract showed significant, dose-dependent anxiolytic effects, with improved behavioral parameters and normalization of biochemical markers, comparable to diazepam at higher doses. Conclusion: The ethanolic leaf extract of Jasminum sambac exhibits notable anxiolytic activity, supporting its traditional use and potential as a natural anxiolytic agent. Keywords: Anxiety disorders; Jasminum sambac; Elevated Plus Maze; Herbal medicine; GABAergic system; Oxidative stress. |
INTRODUCTION
Anxiety disorders such as generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobias, obsessive–compulsive disorder, and post-traumatic stress disorder represent some of the most prevalent neuropsychiatric illnesses globally 1. These conditions affect a substantial proportion of individuals each year and across the lifespan, accounting for a significant share of disability-adjusted life years 2. Clinically, anxiety disorders are marked by persistent fear, worry, and somatic manifestations, including palpitations and excessive sweating. They commonly emerge during adolescence or early adulthood and occur more frequently in females than in males 3. Owing to their negative effects on quality of life, academic performance, and occupational functioning, anxiety disorders pose a major public health challenge 4.
The pathophysiology of anxiety involves imbalances in key neurotransmitter systems, particularly gamma-aminobutyric acid (GABA), serotonin, and noradrenaline 5. The amygdala is central to fear and emotional processing, while GABA functions as the primary inhibitory neurotransmitter in the central nervous system by decreasing neuronal excitability through GABA receptors, which are the main targets of benzodiazepines 6. Serotonergic pathways are crucial for mood regulation, whereas noradrenergic signalling plays an important role in mediating the physiological stress response 7. Although pharmacological therapies such as selective serotonin reuptake inhibitors, serotonin–noradrenaline reuptake inhibitors, and benzodiazepines are widely used, their clinical utility is often restricted by adverse effects.
These adverse effects, including sedation, insomnia, sexual dysfunction, gastrointestinal disturbances, tolerance, dependence, and withdrawal symptoms, can result in poor treatment adherence and highlight the need for safer and better-tolerated alternatives 8,9.
In recent years, complementary and alternative medicine has attracted increasing attention for anxiety management, with herbal therapies being particularly popular due to their accessibility, cultural acceptance, and perceived safety 10. Medicinal plants such as Ginkgo biloba, Valeriana officinalis, and Passiflora incarnata have demonstrated potential anxiolytic activity through modulation of neurotransmitter systems, although the available evidence is often constrained by methodological inconsistencies 11. Jasminum sambac (Arabian jasmine or Mogra), a plant extensively used in Ayurvedic and Unani medicine, has traditionally been employed for the treatment of central nervous system disorders, including anxiety and insomnia, as well as various endocrine, gastrointestinal, and infectious conditions 12,13. Indigenous to the Indian subcontinent and well adapted to tropical environments, J. sambac possesses considerable ethnomedicinal significance 14.
Phytochemical investigations have revealed that Jasminum sambac is rich in bioactive compounds such as flavonoids, alkaloids, terpenoids, essential oils, saponins, glycosides, tannins, and phenolic constituents. These compounds are associated with diverse biological activities, including antioxidant, anti-inflammatory, antimicrobial, and neuropharmacological effects 15. Notably, flavonoids and alkaloids are known to influence GABAergic neurotransmission, which may provide a mechanistic explanation for the plant’s traditional use as an anxiolytic 16.
Despite its widespread traditional application for anxiety relief, the anxiolytic efficacy of the ethanolic leaf extract of Jasminum sambac has not yet been systematically investigated. Therefore, the present study aimed to evaluate the anti-anxiety potential of the ethanolic leaf extract of Jasminum sambac in Swiss albino mice using the Elevated Plus Maze model, with diazepam serving as the standard reference drug. The study encompassed plant collection and authentication, preparation of the ethanolic extract through maceration, preliminary phytochemical screening, and assessment of anxiolytic activity using the Elevated Plus Maze paradigm.
MATERIALS AND METHODS
Plant Material and Extraction
The leaves of Jasminum sambac were obtained from the local market and authenticated by the Department of Botany, Dr H.S. Gour University, Sagar (M.P.).
The Jasminum sambac flower was collected and washed with water. The Jasminum sambac flower (300g) and (600ml) distilled water were placed in a round-bottom flask and connected to a Clevenger apparatus. Hydrodistillation was completed after 5 hours of boiling at a temperature of 60-100 0C. The final extract was cooled and centrifuged to separate the oil. The oil was stored in a refrigerator for further use 17.
Phytochemical Screening
Preliminary phytochemical tests were conducted per Khandelwal (2008) 18 to detect the presence of alkaloids, Flavonoids, Tannins, Phenolics, Carbohydrates, Saponins, and Steroids.
Experimental Animals
Mature Albino Mice (20–25gm) were taken from the animal house of SIPS, Sagar. All animals were kept in standard plastic polypropylene cages with stainless steel coverlids, and wheat straw was used as bedding material. The animals were maintained with a standard environment of photoperiod (12:12 hr dark: light cycle) and room temperature (23±20 °C). The animal is assisted free to feed and given purified water ad libitum. All experiments were conducted according to CPCSEA (SIPS/EC/2023/70) guidelines.
Dose Preparation
The extract was suspended in distilled water using a sonicator. Doses were 100 mg/kg and 200 mg/kg (p.o.). Diazepam (4 mg/kg, p.o.) and saline (10 ml/kg, p.o.) were prepared similarly.
Experimental Design
Table 1: Experimental Grouping, Treatments, Dosage, and Testing Schedule for the Anxiolytic Activity Study of Jasminum sambac
|
S. No |
Group |
Dosing |
|
|
Control Group |
Vehicle Treated |
|
|
Negative Control |
Disease Induced |
|
|
Standard |
Diazepam, 4mg/kg i.p. |
|
|
Test group-I |
Jasminum sambac 100mg/kg |
|
|
Test group-II |
Jasminum sambac 200mg/kg |
Evaluation parameters of anti-anxiety activity:
The statistical analysis was carried out as per the standard method. Results expressed as Mean± SEM were compared with the analysis of variance (ANOVA) followed by Dunnett’s test value for statistical significance.
RESULTS
Extraction Yield: Maceration yielded 3.48 g (3.48% w/w) of dark green, semi-solid extract.
|
S. No. |
Phytochemical Test of Ethanolic extract of Jasminum sambac |
Observations |
Results |
|
1. |
Test for alkaloids
|
Reddish brown ppt. Brown ppt. Reddish brown ppt. Yellow ppt. |
+ - - - |
|
2. |
Test for Carbohydrates
|
Dull violet color Red ppt. Reddish ppt. |
+ + - |
|
3. |
Test for Glycosides
|
No change No change No change |
- - - |
|
5. |
Test for Flavonoids
|
Yellow color turn to colorless Pink color |
+
+ |
|
6. |
Test for Saponins
|
No change |
- |
|
7. |
Test for Phenols and Tannins
|
Blue-blank ppt. Yellow ppt. |
+ + |
(+) Phytoconstituent present and (-) phytoconstituent absent. The extract of Jasminum sambac gives positive test for alkaloids, carbohydrates, flavanoids, phenols and tannins. It gives negative tests for glycosides and for saponins.
Pharmacological Screening:
Table 3: Behavioural parameters are the primary evidence to confirm the presence of anxiety as well as the anti-anxiety effect of treatments.
|
S.No. |
Group |
Elevated Plus Maze |
Force Swim Test |
Light & dark Test |
Open Field Test |
|||
|
Time spent in Open arm (Sec.) |
Time spent in Close arm (Sec.) |
Time Counts in Force Swim Test (Sec.) |
Time spent in Light Area (Sec.) |
Time spent in Dark Area (Sec.) |
No. of Squire Cross in 5 min. |
No. of Rearing In 5 min. |
||
|
1. |
Positive control |
237±5.0382 |
63±2.0126 |
76±2.2108 |
217± 2.3024 |
83± 4.2015 |
48±2.2450 |
24±5.0545 |
|
2. |
Negative control |
41±3.4021 |
260±3.2017 |
35±2.5421 |
56±2.1245 |
244± 2.5045 |
14±2.5402 |
39±5.2540 |
|
3. |
Standard (diazepam 4mg/kg ) |
194± 5.1307** |
106± 6.2016** |
64± 3.5041** |
169± 3.0554** |
131± 4.2045** |
38± 2.2405** |
27± 5.2451** |
|
4. |
Jasminum sambac (100mg/kg) |
118± 3.0124* |
184± 5.3026* |
49± 4.2401* |
135± 6.0215* |
165± 4.3024* |
31± 2.0245* |
35± 2.2405* |
|
5. |
Jasminum sambac (200mg/kg) |
167± 2.5201** |
133± 4.2103** |
58± 4.240*** |
177± 2.3054** |
123± 4.2402** |
34± 2.0454** |
32± 5.4545** |
Values are expressed MEAN±SEM, n=6, ** = P<0.01, *** = P<0.001 when compared to the normal control group, b = ns when compared to the normal control group, a*** = P<0.001 when compared to the negative control group, c = ns when compared to the standard group. Standard: Diazepam (4mg/kg).
|
Time spent in Close arm (Sec.) |
|
100
50 |
|
Time spent in Open arm (Sec.) |
|
R E S P O N S E |
Figure 1: Effect of Jasminum sambac on EPM parameters in Stress-Induced Anxiety in Mice.
|
R e s p o n s e s |
|
90 80 70 60 50 40 30 20 10 0 |
Figure 2: Effect of Jasminum sambac on FST in Stress-Induced Anxiety in Mice.
|
R e s p o n s e s |
|
200 150 100 50 |
Figure 3: Effect of Jasminum sambac on Light and Dark Test in Stress-Induced Anxiety in Mice.
|
40
30 |
|
R e s p o n s e s |
Figure 4: Effect of Jasminum sambac on OFT in Stress-Induced Anxiety in Mice.
|
S. No. |
Groups |
Plasma Nitrate (µmol/l) Griess assay |
iNOS (µmol/l) |
AchE (mg/dl) |
MAO-A (U/gm protein) |
MAO-B (U/gm protein) |
Glutathione Reductase (U/l) |
|
1. |
Positive Control |
24.38± 2.3540 |
103.71± 2.84550 |
54.31± 2.2505 |
64.3± 2.4024 |
49.8± 3.2022 |
1378.7± 2.2012 |
|
2. |
Negative Control |
73.25± 2.2405 |
26.23± 2.5470 |
81.23± 3.0245 |
86.1± 2.3024 |
73.4± 2.2061 |
1634.2± 2.2102 |
|
3. |
Standard |
48.73± 1.9058*** |
98.16± 2.2405*** |
48.72± 3.2301*** |
53.3± 3.2401*** |
43.7± 3.2102*** |
1426.4± 2.2015*** |
|
4. |
Jasminum sambac 100mg/kg |
61.58± 2.2405* |
43.29± 3.1450* |
63.17± 2.0540* |
57.5± 3.2014* |
48.2± 2.3045* |
1624.4± 2.3201* |
|
5. |
Jasminum sambac 200mg/kg |
53.41± 2.2450** |
71.96± 2.5402** |
51.92± 2.3054** |
54.1± 3.3012** |
45.3± 3.2015** |
1483.5± 2.2230** |
Values are expressed MEAN±SEM, n=6, ** = P<0.01, *** = P<0.001 when compared to normal control group, b = ns when compared to the normal control group, a*** = P<0.001 when compared to negative control group, c = ns when compared to standard group. Standard:- Diazepam (4mg/kg)
|
C o n c e n t r a t i o n |
|
90 80 70 60 50 40 30 20 10 0 |
Figure 5: Effect of Jasminum sambac on Plasma Nitrate in Stress-Induced Anxiety in Mice.
|
120 C o100 n c 80 e n t 60 r a 40 t i 20 o n |
Figure 6: Effect of Jasminum sambac on iNOS in Stress-Induced Anxiety in Mice.
|
C o n c e n t r a t i o n |
|
90 80 70 60 50 40 30 20 10 0 |
Figure 7: Effect of Jasminum sambac on AchE in Stress-Induced Anxiety in Mice.
|
C o n c e n t r a t i o n |
|
100 90 80 70 60 50 40 30 20 10 0 |
|
MAO-A MAO-B |
Figure 8: Effect of Jasminum sambac on MAO-A and MAO-B in Stress-Induced Anxiety in Mice.
|
C o n c e n t r a t i o n |
|
2000 1800 1600 1400 1200 1000 800 600 400 200 0 |
Figure 9: Effect of Jasminum sambac on Glutathione Reductase in Stress-Induced Anxiety in Mice.
Histopathology
|
1. Control Group |
2. Negative Control Group |
3. Standard Group |
|
4. Test Group-I |
5. Test Group-II |
CONCLUSION:
The present investigation provides compelling experimental evidence that the ethanolic leaf extract of Jasminum sambac exhibits significant anxiolytic activity in Swiss albino mice. Behavioral assessments using the Elevated Plus Maze, Light and Dark Box, Open Field Test, and Forced Swim Test demonstrated a dose-dependent reduction in anxiety-like behavior, with the higher dose (200 mg/kg) producing effects comparable to the standard anxiolytic drug diazepam.
Phytochemical screening revealed the presence of bioactive constituents such as flavonoids, alkaloids, phenols, and tannins, which are known to influence central nervous system function. Biochemical analyses further supported the behavioral findings by showing modulation of monoamine oxidase activity, reduction in oxidative and nitrosative stress markers, normalization of acetylcholinesterase levels, and enhancement of antioxidant defense mechanisms. These effects suggest that the anxiolytic action of Jasminum sambac may involve interactions with GABAergic and monoaminergic neurotransmission as well as antioxidant pathways.
Overall, the study validates the traditional use of Jasminum sambac in the management of anxiety and supports its potential as a safe and effective natural anxiolytic agent. Further studies involving isolation of active compounds, mechanistic investigations, and clinical evaluation are warranted to fully establish its therapeutic utility.
Conflict of interest: None.
Funding: None.
Ethical approval: All experiments were conducted in accordance with CPCSEA (SIPS/EC/2023/70) guidelines.
Acknowledgement: The authors express their sincere gratitude to the management and staff of Sagar Institute of Pharmaceutical Sciences (Sagar) for their continuous support, encouragement, and provision of necessary facilities to carry out this research work.
REFERENCES
1. Uher R. The global impact of anxiety disorders. The Lancet Psychiatry. 2023 Apr 1;10(4):239-40. https://doi.org/10.1016/S2215-0366(23)00067-6 PMid:36931772
2. Liu X, Yang F, Huang N, Zhang S, Guo J. Thirty-year trends of anxiety disorders among adolescents based on the 2019 Global Burden of Disease Study. General Psychiatry. 2024 Apr 3;37(2):e101288. https://doi.org/10.1136/gpsych-2023-101288 PMid:38595856 PMCid:PMC11002340
3. Hantsoo L, Epperson CN. Anxiety disorders among women: a female lifespan approach. Focus. 2017 Apr;15(2):162-72. https://doi.org/10.1176/appi.focus.20160042 PMid:28966563 PMCid:PMC5613977
4. Xue X, Cheng M, Zhang W. Does education really improve health? A meta‐analysis. Journal of Economic Surveys. 2021 Feb;35(1):71-105. https://doi.org/10.1111/joes.12399
5. Aytemiz L, Sart G, Bayar Y, Danilina M, Sezgin FH. The long-term effect of social, educational, and health expenditures on indicators of life expectancy: an empirical analysis for the OECD countries. Frontiers in Public Health. 2024 Dec 18;12:1497794. https://doi.org/10.3389/fpubh.2024.1497794 PMid:39744376 PMCid:PMC11688634
6. Arora I, Mal P, Arora P, Paul A, Kumar M. GABAergic implications in anxiety and related disorders. Biochemical and Biophysical Research Communications. 2024 Sep 10;724:150218. https://doi.org/10.1016/j.bbrc.2024.150218 PMid:38865810
7. Zhou YS, Meng FC, Cui Y, Xiong YL, Li XY, Meng FB, Niu ZX, Zheng JX, Quan YQ, Wu SX, Han Y. Regular aerobic exercise attenuates pain and anxiety in mice by restoring serotonin-modulated synaptic plasticity in the anterior cingulate cortex. Medicine and science in sports and exercise. 2021 Dec 29;54(4):566. https://doi.org/10.1249/MSS.0000000000002841 PMid:34935710 PMCid:PMC8920021
8. Lagerberg T, Fazel S, Sjölander A, Hellner C, Lichtenstein P, Chang Z. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2022 Mar;47(4):817-23. https://doi.org/10.1038/s41386-021-01179-z PMid:34561608 PMCid:PMC8882171
9. Melaragno AJ. Pharmacotherapy for anxiety disorders: from first-line options to treatment resistance. Focus. 2021 Jun;19(2):145-60. https://doi.org/10.1176/appi.focus.20200048 PMid:34690578 PMCid:PMC8475920
10. Veziari Y, Kumar S, Leach M. Addressing barriers to the conduct and application of research in complementary and alternative medicine: a scoping review. BMC Complementary Medicine and Therapies. 2021 Jul 15;21(1):201. https://doi.org/10.1186/s12906-021-03371-6 PMid:34266441 PMCid:PMC8281683
11. Suciu F, Mihai DP, Ungurianu A, Andrei C, Pușcașu C, Chițescu CL, Ancuceanu RV, Gird CE, Stefanescu E, Blebea NM, Popovici V. Investigation of Anticonvulsant Potential of Morus alba, Angelica archangelica, Valeriana officinalis, and Passiflora incarnata Extracts: In Vivo and In Silico Studies. International Journal of Molecular Sciences. 2025 Jul 3;26(13):6426. https://doi.org/10.3390/ijms26136426 PMid:40650201 PMCid:PMC12250342
12. Atiratana T, Goldson AR, Samosorn S, Rajput N, Praphairaksit N, Kenney JW. The effects of Arabian jasmine on zebrafish behavior depends on strain, sex, and personality. Plos one. 2025 Sep 23;20(9):e0332642. https://doi.org/10.1371/journal.pone.0332642 PMid:40986538 PMCid:PMC12456823
13. Gosavi DD, Kamdi AS, Kalambe GM, Bohra PN. The antianxiety activity of aqueous extract of Withania coagulans fruits in swiss albino mice by elevated plus maze. Int J Basic Clin Pharmacol. 2020 Sep;9(9):1337-42. https://doi.org/10.18203/2319-2003.ijbcp20203617
14. Rattan R. Genus Jasminum: Phytochemicals and Pharmacological effects-a Review. Int J Res Anal Rev. 2023;10:787-95.
15. Silalahi M. Jasmine (Jasminum sambac (L.) Aiton): potential utilization and bioactivity. Asian Journal of Research in Agriculture and Forestry. 2023 Mar 3;9(2):28-36. https://doi.org/10.9734/ajraf/2023/v9i2198
16. Llamasares-Castillo A, Villaflores O, Kuroki Y, Wada A, Zhu X, Cabatit KA, Garcia JJ, Martin J, Vasquez R. Phytotherapeutic Agents for Insomnia: A Scoping Review on the Mechanistic Insights and Evidence from Animal Models. Phytomedicine Plus. 2025 Feb 27:100770. https://doi.org/10.1016/j.phyplu.2025.100770
17. Modarresi M, Mohammadi-Farani A, Amirshahrokhi K, Beheshtizadeh R. Anxiolytic and antidepressant effects of aqueous extract of Stachys lavandulifolia Vahl. in mice. Journal of Reports in Pharmaceutical Sciences. 2020 Jan 1;9(1):31-40. https://doi.org/10.4103/jrptps.JRPTPS_108_19
18. Wallis TE. Practical pharmacognosy. J. & A. Churchill; 1925.